Lv1
80 积分 2023-05-11 加入
Response-Adaptive Surgical Timing in neoadjuvant immunotherapy demonstrates enhanced pathologic treatment response in Head and Neck Squamous Cell Carcinoma
5小时前
已完结
Targeting TFH cells in human diseases and vaccination: rationale and practice
3个月前
已完结
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
3个月前
已完结
A blueprint for tumor-infiltrating B cells across human cancers
4个月前
已完结
Tertiary lymphoid structures in the era of cancer immunotherapy
5个月前
已完结
Tertiary lymphoid structures in cancer
5个月前
已完结
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
5个月前
已完结
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy
5个月前
已完结
The m6A Reader IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression by Maintaining UCA1 Stability
6个月前
已完结
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
7个月前
已完结
皖公网安备34019202002308
